NDC 49702-213

RETROVIR

Zidovudine

RETROVIR is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Zidovudine.

Product ID49702-213_11d2d978-cfce-4ef7-aca5-9d7ec3bf4aa1
NDC49702-213
Product TypeHuman Prescription Drug
Proprietary NameRETROVIR
Generic NameZidovudine
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2010-11-04
Marketing CategoryNDA / NDA
Application NumberNDA019951
Labeler NameViiV Healthcare Company
Substance NameZIDOVUDINE
Active Ingredient Strength10 mg/mL
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 49702-213-26

5 VIAL, SINGLE-USE in 1 CARTON (49702-213-26) > 20 mL in 1 VIAL, SINGLE-USE (49702-213-01)
Marketing Start Date2016-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49702-213-05 [49702021305]

RETROVIR INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019951
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-11-04
Marketing End Date2019-04-30

NDC 49702-213-26 [49702021326]

RETROVIR INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019951
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-12-01

NDC 49702-213-01 [49702021301]

RETROVIR INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019951
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2010-11-04

Drug Details

Active Ingredients

IngredientStrength
ZIDOVUDINE10 mg/mL

OpenFDA Data

SPL SET ID:6df09f15-b102-431c-adde-d7aeef6f5d84
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 204534
  • 756209
  • 201907
  • 755298
  • 198352
  • 108396
  • UPC Code
  • 0349702211209
  • Pharmacological Class

    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "RETROVIR" or generic name "Zidovudine"

    NDCBrand NameGeneric Name
    49702-211RETROVIRzidovudine
    49702-212RETROVIRzidovudine
    49702-213RETROVIRzidovudine
    0378-6106Zidovudinezidovudine
    0527-1905ZidovudineZidovudine
    21695-369ZidovudineZIDOVUDINE
    31722-509ZidovudineZidovudine
    52343-044ZidovudineZidovudine
    52343-045ZidovudineZidovudine
    53104-0100Zidovudinezidovudine
    53104-0101ZidovudineZidovudine
    53104-0105zidovudinezidovudine
    53808-0812ZidovudineZIDOVUDINE
    53808-0878Zidovudinezidovudine
    57237-241ZidovudineZidovudine
    65862-024ZidovudineZidovudine
    65862-048ZidovudineZidovudine
    65862-107ZidovudineZidovudine

    Trademark Results [RETROVIR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RETROVIR
    RETROVIR
    73596206 1418913 Live/Registered
    BURROUGHS WELLCOME CO.
    1986-05-01

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.